01-01-1970 12:00 AM | Source: Reuters
Indias Bharat Biotech to supply Covaxin to states, hospitals at Rs 600-1,200 per dose
India's Bharat Biotech said on Saturday that it will supply Covaxin directly to state governments at 600 rupees per dose, while it will supply the vaccine directly to private hospitals at 1,200 rupees per dose.
In a tweet, the company said it will develop, manufacture and supply Covaxin to India's central government at 150 rupees per dose. https://bit.ly/2S1W3zC
The company added that more than 50% of its vaccine capacities have been reserved for supply to the central government.
(Reporting by Juby Babu in Bengaluru; Editing by Marguerita Choy)
Latest News
Centre launches portal for nurturing skill developme...
Hyundai, Kia`s Europe sales down 7.5 pc in October
AI-powered voice analysis may revolutionise early di...
Rohit Sharma to join Indian team in Australia on Sunday
Evening Roundup : A Daily Report on Bullion Energy &...
Buy Copper Above 825 SL Below 821 TGT 830/833 - Axis...
Over 9 in 10 Indian leaders anticipate an increase i...
Evening Track : Renewed Geopolitical uncertainty fue...
Mahayuti government is going to be formed: Shiv Sena...
Everything will get clear on the 23rd: BJPs Rahul Na...
Tag News
Bharat Biotech evinces interest to invest in Karnataka
Key Stock News: JSW Group , Aditya Birla Fashion and Retail Limited , Bharat Biotech , Adani group - ARETE Securities
Key News - Vedanta Ltd, Mindtree Ltd, Reliance Industries Limited Ltd, Bharat Biotech, Braithwaite & Co Ltd By ARETE Securities
DGCI approves for phase III trial of Bharat Biotech intranasal vaccine as booster